cimetidine has been researched along with Cancer of Salivary Gland in 2 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, M | 2 |
Kusama, K | 2 |
Sakashita, H | 2 |
Tanaka, S | 1 |
Suzuki, S | 1 |
Kaneko, T | 1 |
2 other studies available for cimetidine and Cancer of Salivary Gland
Article | Year |
---|---|
Cimetidine inhibits salivary gland tumor cell adhesion to neural cells and induces apoptosis by blocking NCAM expression.
Topics: Animals; Apoptosis; Cell Adhesion; Cimetidine; Dose-Response Relationship, Drug; Down-Regulation; Ge | 2008 |
Cimetidine induces apoptosis of human salivary gland tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cimetidin | 2007 |